孕妇X受体作为胆固醇性肝损伤的治疗点
Huan Lan1, Ying Zhang1, Minqi Fan1
1International Institute for Translational Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, P.R. China.
Drug metabolism reviews
|August 18, 2023
概括
孕妇X受体 (PXR) 激活通过减少胆酸积累,炎症和纤维化来改善胆固醇性肝损伤. 这篇评论探讨了PXRR.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 胆固醇性肝损伤 (CLI) 是由于有毒胆酸 (BA) 积累而产生的,导致肝炎和纤维化.
- 目前的CLI治疗方法有限,这凸显了针对BA平衡的新型治疗策略的需要.
- 孕妇X受体 (PXR) 调节BA代谢和平衡,显示了CLI治疗的潜力.
研究的目的:
- 审查PXR在改善CLI中的胆固醇,炎症和纤维化中的作用.
- 讨论PXR激动剂治疗CLI的治疗潜力.
主要方法:
- 对研究PXR在胆固醇性肝损伤中的作用的文献综述.
- 分析PXR调节胆酸代谢,炎症和纤维化的机制.
- 已识别的PXR激动剂及其在临床前和临床环境中的疗效的概述.
主要成果:
- 激活PXR通过调节BA平衡来表现出抗胆固醇效应.
- PXR表现出对CLI有益的抗炎和抗纤维素特性.
- 几种PXR激活剂在改善CLI方面表现有前途.
结论:
- PXR在减轻与胆固醇形成相关的肝损伤方面发挥着至关重要的作用.
- 用特定的激动剂向PXR代表了对CLI的有希望的治疗途径.
- 需要进一步的研究来充分阐明PXR的机制,并优化基于PXR的CLI治疗方法.
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
215
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
215
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
199
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
199
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791


